Pharyngeal neoplasm occurs when the cells in the pharynx become
malignant and form an abnormal mass resulting in a tumor. Pharyngeal
neoplasm (pharyngeal cancer, in other words) can occur in three areas
of the pharynx viz. nasopharynx (the upper part, behind the nasal
cavity), oropharynx (the middle part, behind the oral cavity), and
hypopharynx (the bottom part, adjacent to the larynx).
The global pharyngeal neoplasm market can be segmented based on type,
treatment, and geography. Based on type, the pharyngeal neoplasm
market can be divided into nasopharyngeal cancer, oropharyngeal
cancer, and hypopharyngeal cancer. Nasopharyngeal cancers are mostly
squamous cell carcinomas. They are prevalent in Southeast Asia
including countries such as China, Hong Kong, and Malaysia. Various
symptoms of nasopharyngeal cancer are sore throat, bleeding nose,
headache, and a lump in the neck. Oropharyngeal cancer develops at
the base of the tongue, the tonsillar area, and the pharyngeal walls.
Symptoms of the oropharyngeal cancer include cough; change in voice;
a lump in the throat, the neck, and back of the mouth; and presence
of white patches in the oropharynx. Hypopharyngeal cancer is the
least common form of pharyngeal neoplasm. Poor nutrition and
excessive drinking and smoking are a few risk factors for
hypopharyngeal cancer. Symptoms include difficulty in swallowing, ear
pain, sore throat, and a lump in the neck.
Based on treatment, the global pharyngeal neoplasm market can be
segmented into primary resection & selective neck dissection,
radiotherapy, chemotherapy, biological therapy, and hyperthermia.
Radiotherapy includes stereotactic radiosurgery and proton beam
therapy. Stereotactic radiosurgery treatment involves a high dosage
of particular radiation to the tumor area in a single session or
multiple sessions. The proton beam therapy method employs a beam of
protons instead of X-rays to kill cancer cells. The beam of protons
releases energy both before and after it hits the target. Moreover,
it causes minor damage to tissues while passing through them. Proton
beams release their energy after traveling a certain distance.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36059
Based on geography, the global pharyngeal neoplasm market can be
segmented into four major regions: North America, Europe, Asia
Pacific, and Rest of World. North America dominates the global
pharyngeal neoplasm market, followed by Europe. Key factors driving
the market in these two regions are growing awareness about malignant
effects of tumor among the people and availability of sophisticated
and technologically advanced treatment options. According to a
publication of the American Cancer Society, around 49,670 individuals
in the U.S. were diagnosed with the oropharyngeal cancer in 2016.
Additionally, increasing unhealthy lifestyle habits such as smoking
and drinking is also contributing to growth of the pharyngeal
neoplasm market in North America. Asia Pacific is one of the most
promising markets for pharyngeal neoplasm, as the region has
countries developing rapidly. Factors that propel the market in Asia
Pacific are high prevalence of pharyngeal neoplasm; high population
density in countries in Southeast Asia such as China, Malaysia, and
Singapore; and government support for improvement in health care
infrastructure in the region. Furthermore, presence of developing
economies and easy penetration of the market in developing countries
in Asia would drive the pharyngeal neoplasm market in Asia Pacific in
the near future.
Several pharmaceutical companies are currently developing therapeutic
treatments to reduce the malignant effects of the pharyngeal
neoplasm. Some of the top players operating in the global pharyngeal
neoplasm market are F. Hoffmann-La Roche Ltd., Cyclacel
Pharmaceuticals, Inc., Biotech Pharmaceuticals Co., Ltd.,
Sanofi-Aventis, Prima BioMed Limited, and YM BioSciences, Inc.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=36059<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment